This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Alissa Pharma, LLC
Drug Names(s): 90Y antiferritin polyclonal antibody, Ferritarg P, Yttrium (90Y) antiferritin, Y90-anti-ferritin
Description: Ferritarg is an yttrium 90-conjugated anti-ferritin rabbit polyclonal antibody. (The antibody is conjugated to Indium 111 for diagnostic use.)
Ferritarg was originally developed at two US institutions, Johns Hopkins and MD Anderson, and by MAT Biopharma (formerly Monoclonal Antibodies Therapeutics; now MABLife).
Alissa Pharma owns the worldwide rights for Ferritarg in all radiopharmaceutical indications.
Additional information available to subscribers only: